ResMed, Inc. (RMD)
229.12
-1.75
(-0.76%)
USD |
NYSE |
Sep 03, 16:00
229.12
0.00 (0.00%)
After-Hours: 18:26
ResMed Research and Development Expense (TTM) : 378.28M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 378.28M |
| March 31, 2026 | 359.00M |
| December 31, 2025 | 348.68M |
| September 30, 2025 | 339.08M |
| June 30, 2025 | 331.28M |
| March 31, 2025 | 325.70M |
| December 31, 2024 | 318.83M |
| September 30, 2024 | 311.34M |
| June 30, 2024 | 307.52M |
| March 31, 2024 | 304.81M |
| December 31, 2023 | 304.17M |
| September 30, 2023 | 300.16M |
| June 30, 2023 | 287.64M |
| March 31, 2023 | 273.82M |
| December 31, 2022 | 264.18M |
| September 30, 2022 | 256.81M |
| June 30, 2022 | 253.58M |
| March 31, 2022 | 249.13M |
| December 31, 2021 | 238.27M |
| September 30, 2021 | 230.70M |
| June 30, 2021 | 225.28M |
| March 31, 2021 | 217.93M |
| December 31, 2020 | 213.44M |
| September 30, 2020 | 208.44M |
| June 30, 2020 | 201.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 200.56M |
| December 31, 2019 | 196.72M |
| September 30, 2019 | 189.89M |
| June 30, 2019 | 180.65M |
| March 31, 2019 | 169.17M |
| December 31, 2018 | 158.99M |
| September 30, 2018 | 156.52M |
| June 30, 2018 | 155.15M |
| March 31, 2018 | 152.20M |
| December 31, 2017 | 149.89M |
| September 30, 2017 | 147.44M |
| June 30, 2017 | 144.47M |
| March 31, 2017 | 142.15M |
| December 31, 2016 | 135.12M |
| September 30, 2016 | 125.90M |
| June 30, 2016 | 118.65M |
| March 31, 2016 | 112.79M |
| December 31, 2015 | 111.71M |
| September 30, 2015 | 112.03M |
| June 30, 2015 | 114.86M |
| March 31, 2015 | 118.14M |
| December 31, 2014 | 120.64M |
| September 30, 2014 | 120.89M |
| June 30, 2014 | 118.23M |
| March 31, 2014 | 117.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Koninklijke Philips NV | 2.005B |
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Medtronic Plc | 2.918B |
| Orthofix Medical, Inc. | 60.33M |